Wide Ranks

LNSR

LENSAR, Inc.

7.69

Top Statistics
Market Cap 89 M Forward PE -13.49 Revenue Growth 38.20 %
Current Ratio 3.37 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -34.03 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -13.67 Enterprise / Revenue 1.78 Price To Sales Trailing12 Months 1.83
Profitability
Profit Margins -34.03 % Operating Margins -9.20 %
Balance Sheet
Total Cash 18 M Total Cash Per Share 1.56 Total Debt 1 M
Total Debt To Equity 5.18 Current Ratio 3.37 Book Value Per Share 1.96
All Measures
Short Ratio 93.00 % Message Board Id finmb_41699596 Shares Short Prior Month 64312
Return On Equity -0.3838 City Orlando Uuid 662890c4-c223-347e-b1b1-cd1fe315c6d7
Previous Close 7.44 First Trade Date Epoch Utc 1 B Book Value 1.96
Beta 0.5850 Total Debt 1 M Volume 21779
Price To Book 3.93 Fifty Two Week Low 2.12 Total Cash Per Share 1.56
Total Revenue 48 M Shares Short Previous Month Date 1 B Target Median Price 11.00
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -9.20 %
Target Mean Price 11.00 Net Income To Common -16628000 Short Percent Of Float 0.0045
Implied Shares Outstanding 11 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 50610 Average Volume10days 50610 Total Cash 18 M
Next Fiscal Year End 1 B Revenue Per Share 4.28 Held Percent Insiders 0.1957
Ebitda Margins -13.01 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 7.44 Target Low Price 10.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 5.73 Open 7.50
Dividend Yield 0.00 % State FL Return On Assets -0.0938
Time Zone Short Name EST Trailing Eps -1.46 Day Low 7.43
Address1 2800 Discovery Drive Shares Outstanding 11 M Price Hint 2
Target High Price 12.00 Website https://www.lensar.com 52 Week Change 2.09
Average Volume 36278 Forward Eps -0.7100 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 192.30 % Is_sp_500 False
Regular Market Day High 7.91 Profit Margins -34.03 % Debt To Equity 5.18
Fifty Two Week High 8.17 Day High 7.91 Shares Short 43676
Regular Market Open 7.50 Industry Key medical-devices Earnings Growth 0.00 %
Enterprise To Revenue 1.78 Revenue Growth 38.20 % Shares Percent Shares Out 0.0038
Currency USD Time Zone Full Name America/New_York Market Cap 89 M
Is_nasdaq_100 False Zip 32826 Quote Type EQUITY
Industry Medical Devices Long Name LENSAR, Inc. Regular Market Day Low 7.43
Held Percent Institutions 0.4242 Current Price 7.69 Enterprise To Ebitda -13.67
Financial Currency USD Current Ratio 3.37 Gross Margins 48.89 %
Industry Disp Medical Devices Number Of Analyst Opinions 2 Country United States
Float Shares 8 M Two Hundred Day Average 4.61 Enterprise Value 86 M
Price To Sales Trailing12 Months 1.83 Forward PE -13.49 Regular Market Volume 21779
Ebitda -6357000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism.

It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room.

LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.